Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
The article breaks down the core factors behind price stability in stablecoins, including peg design, reserve backing, and market liquidity.
23,217 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
TJX posted a strong fourth quarter ahead of expectations, yet conservative guidance sparked a pullback in shares as i...
When geopolitics and supply chains collide, a single stock can surge. This article breaks down why rare earth stock s...
UBS lifts H World, Wells Fargo reprises Netflix coverage, and JD.com shares a reduced target as institutional views s...
Analysts outline a path to higher earnings for Southwest in 2026, but fuel costs and customer fees remain key risks. ...
In uncertain markets, reliable dividends can power steady income. This article uncovers two dividend stocks double ri...
A major fund just walked away from its Li Auto position, selling roughly $33 million worth of shares in one quarter. ...
When a director sells shares after a sharp gain, it can spark questions about the stock’s future. This article breaks...
In April, Oklo delivered a sharp rebound that captured investor attention. This in-depth look explains the catalysts,...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
A major fund just raised its stake in a leading data-center company. This article breaks down what that move could me...
A stock can drop today for many reasons—some temporary, some signaling a bigger issue. This guide shows you how to ev...